Both in Biotechnology
IRulya Therapeutics vs Entera Bio
Over the past year IRLA returned +22.8% and ENTX returned +21.5%; their daily moves had a correlation of 0.57.
IRLA +22.8% ENTX +21.5%Growth of $1, one year, split-adjusted
| Metric | IRLA | ENTX |
|---|---|---|
| Price | $39.78 | $3.22 |
| Market cap | $431.3M | $560.7M |
| Today | +3.78% | 0.00% |
| 1 month | +32.6% | +28.8% |
| 6 months | — | +143.9% |
| Year to date | — | +66.0% |
| 1 year | — | +7.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $11.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 59.3% |
| Short % of float | 14.2% | 4.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).